Notably, the lack of an increase in IL-10 in SARS-CoV infection has been suggested to contribute to immune-mediated lung damage early on (75) and, more recently, to the higher frequency of fatal aggravation of lung injury in SARS compared to COVID-19 (80). The gene discussed is IL10; the disease is COVID-19.